Insider Transactions in Q2 2022 at Pyxis Oncology, Inc. (PYXS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2022
|
Mark Chin |
SELL
Open market or private sale
|
Indirect |
1,745,761
-100.0%
|
$5,237,283
$3.05 P/Share
|
|
Apr 14
2022
|
Lara Sullivan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
315,273
+18.86%
|
-
|
|
Apr 14
2022
|
Jay Feingold Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
115,931
+19.9%
|
-
|
|
Apr 14
2022
|
Connealy Pamela Yanchik CFO & COO |
BUY
Grant, award, or other acquisition
|
Direct |
93,493
+21.52%
|
-
|